Literature DB >> 6101431

Cytotoxic enteropathogenic Escherichia coli.

S M Scotland, N P Day, G A Willshaw, B Rowe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6101431     DOI： 10.1016/s0140-6736(80)90510-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Toxin production and haemagglutination in strains of Escherichia coli from diarrhoea in Brescia, Italy.

Authors:  R Bisicchia; R Ciammarughi; A Caprioli; V Falbo; F M Ruggeri
Journal:  J Hyg (Lond)       Date:  1985-10

2.  Oligomerization of esculin improves its antibacterial activity and modulates antibiotic resistance.

Authors:  Imen Mokdad-Bzeouich; Nadia Mustapha; Fadwa Chaabane; Zied Ghedira; Kamel Ghedira; Mohamed Ghoul; Latifa Chebil; Leila Chekir-Ghedira
Journal:  J Antibiot (Tokyo)       Date:  2014-09-24       Impact factor: 2.649

3.  Partial purification and characterization of an escherichia coli toxic factor that induces morphological cell alterations.

Authors:  A Caprioli; V Falbo; L G Roda; F M Ruggeri; C Zona
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

Review 4.  Escherichia coli diarrhoea.

Authors:  R J Gross; B Rowe
Journal:  J Hyg (Lond)       Date:  1985-12

5.  Biological Activities and Chemical Characterization of Cordia verbenacea DC. as Tool to Validate the Ethnobiological Usage.

Authors:  Edinardo Fagner Ferreira Matias; Erivânia Ferreira Alves; Beatriz Sousa Santos; Celestina Elba Sobral de Souza; João Victor de Alencar Ferreira; Anne Karyzia Lima Santos de Lavor; Fernando Gomes Figueredo; Luciene Ferreira de Lima; Francisco Antônio Vieira Dos Santos; Flórido Sampaio Neves Peixoto; Aracélio Viana Colares; Aline Augusti Boligon; Rogério de Aquino Saraiva; Margareth Linde Athayde; João Batista Teixeira da Rocha; Irwin Rose Alencar Menezes; Henrique Douglas Melo Coutinho; José Galberto Martins da Costa
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-02       Impact factor: 2.629
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.